A Novel Cardiotropic Murine Adenovirus Representing a Distinct Species of Mastadenoviruses
- 1 June 2009
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (11) , 5749-5759
- https://doi.org/10.1128/jvi.02281-08
Abstract
During cell culture isolation experiments to recover Dobrava hantavirus from a suspension of liver from a striped field mouse (Apodemus agrarius), an unknown virus was coisolated. Atypically for hantaviruses, it had extensive cytopathic effects. Using a random PCR approach, it was identified as a novel murine adenovirus, MAdV-3 (for MAdV type 3). A plaque-purified virus clone was prepared and further characterized. The complete genome sequence of MAdV-3 was determined to be 30,570 bp in length. Sequence comparisons to other adenovirus species revealed highest similarity to MAdV-1, the representative of the murine adenovirus A species. However, substantial differences were found in the E1, E3, and E4 genomic regions. The phylogenetic distance of MAdV-3 amino acid sequences for pVIII, protease, polymerase, and hexon from MAdV-1 is markedly higher than 0.1 exchange per position, and, based on our cross-neutralization experiments, MAdV-3 and MAdV-1 can be regarded as different serotypes. Therefore, we propose to classify MAdV-3 as the first isolate of a novel adenovirus species, designated murine adenovirus C (MAdV-C). The novel MAdV-3 virus is not only genetically and serologically distinct from MAdV-1 but also shows a unique organ tropism in infected mice. In contrast to MAdV-1, the virus was not detectable in brain but predominantly infected heart tissue. Thus, infection of mice with cardiotropic MAdV-3 might be an interesting animal model of adenovirus-induced myocarditis.Keywords
This publication has 35 references indexed in Scilit:
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialPublished by Elsevier ,2008
- A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005Journal of Clinical Virology, 2008
- Acute viral myocarditisEuropean Heart Journal, 2008
- Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human AdenovirusMolecular Therapy, 2008
- Single-Dose Protection againstPlasmodium bergheiby a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron AJournal of Virology, 2008
- Viral Persistence in the Myocardium Is Associated With Progressive Cardiac DysfunctionCirculation, 2005
- Genetic content and evolution of adenovirusesJournal of General Virology, 2003
- Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmidGene Therapy, 1999
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Age and susceptibility of Swiss mice for mouse adenovirus, strain FLArchiv für die gesamte Virusforschung, 1980